Cargando…
Three-dimensional (3D) liver cell models - a tool for bridging the gap between animal studies and clinical trials when screening liver accumulation and toxicity of nanobiomaterials
Despite the exciting properties and wide-reaching applications of nanobiomaterials (NBMs) in human health and medicine, their translation from bench to bedside is slow, with a predominant issue being liver accumulation and toxicity following systemic administration. In vitro 2D cell-based assays and...
Autores principales: | Tutty, Melissa Anne, Movia, Dania, Prina-Mello, Adriele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066991/ https://www.ncbi.nlm.nih.gov/pubmed/35507131 http://dx.doi.org/10.1007/s13346-022-01147-0 |
Ejemplares similares
-
Evaluating nanobiomaterial-induced DNA strand breaks using the alkaline comet assay
por: Tutty, Melissa Anne, et al.
Publicado: (2022) -
Correction: Evaluating nanobiomaterial-induced DNA strand breaks using the alkaline comet assay
por: Tutty, Melissa Anne, et al.
Publicado: (2022) -
In vitro Alternatives to Acute Inhalation Toxicity Studies in Animal Models—A Perspective
por: Movia, Dania, et al.
Publicado: (2020) -
Preclinical Development of Orally Inhaled Drugs (OIDs)—Are Animal Models Predictive or Shall We Move Towards In Vitro Non-Animal Models?
por: Movia, Dania, et al.
Publicado: (2020) -
Pre-clinical 2D and 3D toxicity response to a panel of nanomaterials; comparative assessment of NBM-induced liver toxicity
por: Tutty, Melissa Anne, et al.
Publicado: (2022)